Altre lingue Evotec SE

Azioni

EVT

DE0005664809

Mercato chiuso - Xetra Altri mercati azionari 17:43:00 10/05/2024			Variaz. 5gg	Var. 1 gen.
9,52 ^EUR	-1,30%		-2,46%	-55,26%

06/05	EVOTEC : Warburg Research conferma il rating Buy	ZD
03/05	EVOTEC : RBC ottimista sul caso	ZD

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Evotec : Finanzpublikationen Dokument (Jahresabschluss EvotecSE 2023 DE Website)	10/05
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	08/05
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	07/05
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	06/05
DD: Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system.	03/05
DD: Evotec SE: Dr. Cord Dohrmann, Gesperrte Aktien gewährt als kurzfristige variable Vergütung (Bonus) für 2023 gemäß Evotecs Vergütungssystem.	03/05
DD: Evotec SE	03/05
HV: Evotec SE: Bekanntmachung der Einberufung zur Hauptversammlung am 10.06.2024 in Hamburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG	03/05
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	03/05
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	03/05
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	03/05
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	03/05
Bayer : collaboration stratégique avec Evotec	30/04
Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies	30/04
Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases	30/04
Bayer kooperiert mit Evotec in Forschung zu Präzisionskardiologie	30/04
Bayer and Evotec Collaborate to Advance Precision Cardiology	30/04
Bayer und Evotec vereinbaren Forschungskollaboration in der Präzisionskardiologie	30/04
Bayer and Evotec collaborate to advance precision cardiology	30/04
Bayer und Evotec vereinbaren Forschungskollaboration in der Präzisionskardiologie	30/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Evotec SE

Azioni

EVT

DE0005664809

Altre lingue

Filtri